Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reversing Microvascular Dysfunction in Heart Failure With Ejection Fraction > 40% Using Colchicine (The COL-Micro-HF Study)

NCT06217120 is registered in ClinicalTrials.gov with Montreal Heart Institute as lead sponsor.

NCT NCT06217120
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06217120 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reversing Microvascular Dysfunction in Heart Failure With Ejection Fraction > 40% Using Colchicine (The COL-Micro-HF Study)
Lead sponsor
Montreal Heart Institute
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 1, 2024
Completion date
March 1, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction, microvascular coronary artery disease